Literature DB >> 19665237

Complement production by trophoblast cells at the feto-maternal interface.

Roberta Bulla1, Fleur Bossi, Chiara Agostinis, Oriano Radillo, Francesca Colombo, Francesco De Seta, Francesco Tedesco.   

Abstract

An important role played by trophoblast cells at the feto-maternal interface is to exert immunomodulatory functions, including recognition of bacterial and viral agents and recruitment of leucocytes to eradicate pathogens. In this study we present data showing that the trophoblast cell line HTR8/SVneo and freshly isolated human first trimester trophoblast cells (CTBs) synthesize complement molecules C4, C3 and the late complement components, as assessed by ELISA and RT-PCR. Both cell types secrete C4 and C3, and HTR8/SVneo trophoblast cells secrete C6 in a measurable amount. The expression of C4 by HTR8/SVneo trophoblast cells and of C3 and C4 by CTBs was up-regulated by IFNgamma, while IL-1alpha and TNFalpha had no effect on the expression of complement components. In conclusion, we show that trophoblast cells produce complement components, and that synthesis of these proteins may be regulated by the pro-inflammatory cytokine IFNgamma. Complement synthesis by trophoblast cells potentially contributes to placental immune defence from pathogen infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665237     DOI: 10.1016/j.jri.2009.06.124

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  20 in total

1.  Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage.

Authors:  Eun Na Kim; Bo Hyun Yoon; Joong Yeup Lee; Doyeong Hwang; Ki Chul Kim; JoonHo Lee; Jae-Yoon Shim; Chong Jai Kim
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

Review 2.  Complement activation, a threat to pregnancy.

Authors:  Guillermina Girardi
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

3.  Placental C4d as a common feature of chromosomally normal and abnormal miscarriages.

Authors:  Joong Yeup Lee; Joon-Seok Hong; Eun Na Kim; Soyeon Ahn; Jin Choe; Doyeong Hwang; Ki Chul Kim; Seok Hyun Kim; Chong Jai Kim
Journal:  Virchows Arch       Date:  2014-03-27       Impact factor: 4.064

4.  Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.

Authors:  Shari E Gelber; Elyssa Brent; Patricia Redecha; Giorgio Perino; Stephen Tomlinson; Robin L Davisson; Jane E Salmon
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422

Review 5.  The Complement System and Preeclampsia.

Authors:  Jean F Regal; Richard M Burwick; Sherry D Fleming
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

Review 6.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

7.  Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells.

Authors:  Chong Feng; Zhen Jin; Lei Sun; Xiaoyan Wang; Xinshu Chi; Xuan Zhang; Siyu Lian
Journal:  Mol Biol Rep       Date:  2019-07-03       Impact factor: 2.316

Review 8.  Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy.

Authors:  Ai-Ris Y Collier; Laura A Smith; S Ananth Karumanchi
Journal:  Hum Immunol       Date:  2021-02-05       Impact factor: 2.850

Review 9.  The Role of Immune Factors in Shaping Fetal Neurodevelopment.

Authors:  Alice Lu-Culligan; Akiko Iwasaki
Journal:  Annu Rev Cell Dev Biol       Date:  2020-07-28       Impact factor: 11.902

10.  The complement system at the embryo implantation site: friend or foe?

Authors:  R Bulla; F Bossi; F Tedesco
Journal:  Front Immunol       Date:  2012-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.